Skip navigation
Sitemap
Menu
Search

Roy E. Strowd, MD, MEd, MS

  • Medical Oncology and Hematology
  • Neuro-Oncology
  • Neurology
  • Brain Tumor Specialty Team
Contact
See More Locations
Wake Forest Baptist Provider
Accepts New Patients
Treats only Adults
AboutConditions & TreatmentsLocationsCredentialsResearch InterestsBack to Top

About

Practicing Specialties

Medical Oncology and HematologyNeuro-OncologyNeurologyBrain Tumor Specialty Team

Languages

English

Biography

I am a neurologist, neuro-oncologist, clinical trialist, and educator who specializes in brain, spinal cord, and peripheral nerve tumors. I am an expert in brain tumor treatment and lead several national, multi-institution clinical trials through large cooperative groups including the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology. I also specialize in inherited tumor syndromes. I co-direct the Neurofibromatosis and Tuberous Sclerosis Clinics. My research is advancing the field of neuro-oncology by discovering new treatments, new tools to assess whether treatment is working, and improving the quality of life for patients. As an educator, I am passionate about developing the next generation of healthcare leaders. I am Assistant Dean of Undergraduate Medical Education and work with students from high school to college, medical school, residents, and fellows. I am Associate Editor and Section Editor for Medical Education Online and the Resident & Fellow Section of Neurology. I have published >100 articles on these topics, been funded by NIH and other major funders, and collaborate nationally and internationally. 

Most importantly, I am dedicated to providing unparalleled care to patients. I care deeply for my patients. I make sure all my patients are given the time they need to address all of their needs. I am passionate about treating the whole patient and family with respect and compassion.

Current Research

  1. Discovering new treatments for glioblastoma: I lead national clinical studies of new treatments including first-in-class drugs (NCT03216499), targeted therapies (NCT03796273), dietary treatments (NCT02286167), and immunotherapies (KL2TR001421).
  2.  Personalized treatment for brain tumors: I collaborate with scientists to develop patient-specific tumor organoids that predict why tumors become resistant to treatment and how to personalize therapy (R21CA229027).
  3. Improving the lives of patients with NF and TSC: I contribute to new approaches for these diseases (PMID31583187).
  4. Managing neurologic complications of cancer treatment: I lead translational studies to find new biomarkers and novel treatments for chemotherapy-induced neuropathy (R21CA248106).

Conditions and Treatments

Brain TumorChemotherapyNeurofibromatosis (NF)Tuberous Sclerosis

Ratings and Reviews

Locations

Credentials

Internships

Wake Forest University School of Medicine, Internal Medicine, 2010

Residencies

Wake Forest University School of Medicine, Neurology, 2013

Positions

Wake Forest School of Medicine, Associate Professor, Clinical and Translational Science Institute (Winston-Salem)Neurology (Winston-Salem), Associate ProfessorWake Forest School of Medicine, Associate Professor, Cancer Medicine (Winston-Salem)Wake Forest School of Medicine, Associate Professor, Wake Forest Institute for Regenerative Medicine (Winston-Salem)

Research Interests

Brain and Peripheral Nervous System TumorsChemotherapy-Induced Peripheral NeuropathyDrug DevelopmentGlioblastomaNeuro-OncologyNeurofibromatosisParaneoplastic Neurological SyndromesPrecision OncologyTuberous Sclerosis

Publications